US Patent Issued to JAZZ PHARMACEUTICALS RESEARCH UK on June 23 for "Use of cannabidiol in the treatment of epilepsy" (British, American Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,365, issued on June 23, was assigned to JAZZ PHARMACEUTICALS RESEARCH UK Ltd. (Sittingbourne, Great Britain).

"Use of cannabidiol in the treatment of epilepsy" was invented by Jie Li (Carlsbad, Calif.), Kevin James Craig (Sittingbourne, Great Britain), Daniel Adam Checketts (Sittingbourne, Great Britain) and David John Critchley (Sittingbourne, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of cannabidiol (CBD) in the treatment of patients with childhood-onset epilepsy who are concurrently taking caffeine. Where the CBD is used in combination with caffeine, caution should be taken. For example, ...